Ocrelizumab for Treating Patients with Primary Progressive Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Peter Auguste* (Corresponding Author), Jill Colquitt, Martin Connock, Emma Loveman, Rachel Court, Olga Ciccarelli, Carl Counsell, Xavier Armoiry

*Corresponding author for this work

Research output: Contribution to journalReview article

1 Citation (Scopus)

Fingerprint Dive into the research topics of 'Ocrelizumab for Treating Patients with Primary Progressive Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal'. Together they form a unique fingerprint.

Medicine & Life Sciences